State of Wyoming’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-950
Closed -$65.6K 1991
2025
Q2
$65.6K Buy
950
+400
+73% +$27.2K 0.01% 1427
2025
Q1
$38.2K Buy
+550
New +$45.4K 0.01% 1533
2022
Q2
Sell
-20
Closed -$1K 2061
2022
Q1
$1K Sell
20
-4
-17% -$205 ﹤0.01% 1742
2021
Q4
$1K Sell
24
-4
-14% -$217 ﹤0.01% 1819
2021
Q3
$1K Sell
28
-24
-46% -$1.16K ﹤0.01% 1187
2021
Q2
$2K Buy
52
+28
+117% +$1.08K ﹤0.01% 1118
2021
Q1
$1K Buy
+24
New +$855 ﹤0.01% 493

Other funds holding NVO

State of Wyoming's NVO Position: Q3 2025 in Review

State of Wyoming sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 950 shares — an estimated $65.6K sold.

State of Wyoming first reported a position in NVO in Q1 2021 and held it in 7 quarters. The position peaked at $65.6K in Q2 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • State of Wyoming reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • State of Wyoming sold 950 Novo Nordisk shares in Q3 2025, an estimated $65.6K.
  • State of Wyoming first reported a position in Novo Nordisk in Q1 2021 and held it in 7 quarters.
  • State of Wyoming's Novo Nordisk position peaked at $65.6K in Q2 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on State of Wyoming's 13F filing for Q3 2025, filed 4 Nov 2025.